Data / New clinical trials / Kidney Diseases
Kidney Diseases trials: 133 new since Nov 2024
The full list. New Kidney Diseases clinical trials: 133 rows for $6.65, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. The list gains about 5 rows a month. The new rows come each week by email, $19 a month.
Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (central contact, contact phone, contact email, sponsor class, condition groups (MeSH), interventions and 5 more), which open on your screen as soon as the payment clears and come by email. The weekly rows run until you cancel, from the link in each delivery. The rows on this page are a sample.
For agents and scripts: this list is ordered at https://specstream.ai/data/clinical-trials/condition/kidney-diseases, and every list with its row count and price is at https://specstream.ai/data/lists.json.
Updated November 2, 2026. Source: ClinicalTrials.gov API v2 (U.S. National Library of Medicine).
133 clinical studies in Kidney Diseases were first posted on ClinicalTrials.gov from November 13, 2024 to November 2, 2026; 34 have an industry sponsor and 101 are recruiting or about to. The newest, NCT07911033, was posted on November 2, 2026: Relationship Between Insulin Dose and Complications in Type 1 Diabetes (Rachel Miller).
The request: Every new Kidney Diseases clinical trial on ClinicalTrials.gov, with the sponsor, phase, sites and the listed contact. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.
- 133New trials
- 34Industry sponsored
- 101Recruiting or not yet
- November 2, 2026Latest posted
Newest trials
The newest 100 of 133, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.
| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Countries | Source |
|---|---|---|---|---|---|---|---|---|---|
| November 2, 2026 | NCT07911033 | Relationship Between Insulin Dose and Complications in Type 1 Diabetes | Rachel Miller | Observational | Not yet recruiting | Diabetes Mellitus, Type 1 Diabetes, Cardiovascular Diseases (CVD), Severe Albuminuria, Estimated Glomerular Filtration... | 80 | United States | clinicaltrials.gov |
| October 29, 2026 | NCT07902817 | A Phase 3 Blinded Study of JADE101 in Participants With Immunoglobulin A Nephropathy | Jade Biosciences, Inc. | Phase 3 | Recruiting | IgA Nephropathy (IgAN) | 480 | United States | clinicaltrials.gov |
| October 23, 2026 | NCT07891975 | Modulatory Effects of Resveratrol Supplement Along With and Without Low Glycemic Index Diet Among Obese Patients With Diabetic Nephropathy | University of Lahore | Not applicable | Completed | Liver Biomarkers, Glucose, Lipid Profiles | 102 | Pakistan | clinicaltrials.gov |
| October 15, 2026 | NCT07875010 | Wearable NH₃ Sensor for Remote Non-invasive Monitoring and Diagnosis of Diabetic Kidney Disease | Shanghai Pudong Hospital | Observational | Active not recruiting | Diabetic Nephropathies MeSH:D003928, Diabetes Mellitus, Type 2, Kidney Diseases | 380 | China | clinicaltrials.gov |
| October 2, 2026 | NCT07854808 | Trial Without Borders IMPLEMENT-CKD: IMPLEMENTation of Evidence-Based SGLT2i to Reduce Global Burden of Cardiovascular and Chronic Kidney... | The University of Queensland | Observational | Not yet recruiting | Implementation Research, Kidney Disease, Cardiovascular Disease, Chronic Illness | 1,390 | Fiji, Samoa, Thailand | clinicaltrials.gov |
| October 2, 2026 | NCT07854249 | A Study to Evaluate the Pharmacokinetics and Safety of INCB161734 in Participants With Impaired Renal Function and Participants on... | Incyte Corporation | Phase 1 | Not yet recruiting | Renal Insufficiency, Kidney Diseases | 24 | clinicaltrials.gov | |
| September 30, 2026 | NCT07848828 | Autonomic and Renal Contributions to Hypertension With ADT | Virginia Commonwealth University | Phase 4 | Recruiting | Androgen Deprivation Therapy, Prostate Cancer, Hypertension, Autonomic Dysfunction, Renal Disease | 60 | United States | clinicaltrials.gov |
| August 31, 2026 | NCT07794631 | Strategies to Transform Kidney Care and Improve Pursuit of Transplant | The Methodist Hospital Research Institute | Not applicable | Active not recruiting | Kidney Disease, Kidney Transplant, Deceased Donor Kidney Transplant, Living Donor Kidney Transplantation, Chronic... | 5,000 | United States | clinicaltrials.gov |
| August 25, 2026 | NCT07785739 | Clinical Prediction Model for Disease Progression in Primary Membranous Nephropathy | Assiut University | Observational | Not yet recruiting | Membranous Nephropathy, Nephrotic Syndrome, Kidney Diseases | 128 | clinicaltrials.gov | |
| August 21, 2026 | NCT07780045 | SII and SIRI as Prognostic Biomarkers in Lupus Nephritis | Assiut University | Observational | Not yet recruiting | Lupus Nephritis, Systemic Lupus Erythematosus, Kidney Diseases | 100 | clinicaltrials.gov | |
| August 20, 2026 | NCT07775482 | Finerenone for AKI: a Multicenter, Randomized, Placebo-Controlled Feasibility Pilot Trial | Jean-Maxime Côté | Not applicable | Not yet recruiting | Acute Kidney Injury, Renal Insufficiency,Chronic, Kidney Diseases | 72 | Canada | clinicaltrials.gov |
| August 14, 2026 | NCT07766707 | Local and Systemic Inflammatory Bone Alterations Related to Dental Implant Survival. | University of Barcelona | Observational | Active not recruiting | Peri Implant Mucositis, Peri Implant Bone Loss, Peri Implantitis, Calcium Deficiency, Phosphorus and Calcium Disorders... | 192 | Spain | clinicaltrials.gov |
| August 12, 2026 | NCT07760363 | Pedal Pump Clinical Trial on Edema V1 | David McVay | Not applicable | Recruiting | Lower Extremity Edema, Congestive Heart Failure(CHF), Chronic Venous Insufficiency (CVI), Kidney Disease | 60 | United States | clinicaltrials.gov |
| August 11, 2026 | NCT07757269 | ABO/Rh Blood Group Phenotypes as Predictor of Treatment Outcomes in Diabetic Kidney Disease | Cairo University | Observational | Completed | Kidney Disease | 161 | Egypt | clinicaltrials.gov |
| August 7, 2026 | NCT07753681 | Domestication and Implementation of the PEN-Plus Clinical Model in the Zambian Health System | Centre for Infectious Disease Research in Zambia | Observational | Recruiting | Cardiac Diseases, Sickle Cell Disease, Hypertension, Diabetes Mellitus, Heart Failure, Congenital Heart Disease... | 2,084 | Zambia | clinicaltrials.gov |
| August 4, 2026 | NCT07746219 | The Clinical Research of Traditional Chinese Medicine Formula | The Fourth Affiliated Hospital of Zhejiang University School of Medicine | Phase 4 | Not yet recruiting | Urologic Injuries, Kidney Disease | 80 | clinicaltrials.gov | |
| July 31, 2026 | NCT07740083 | The Effect of Patient Empowerment Learning (With AI) About Itching in Hemodylasis Patients. | Izmir Tinaztepe University | Not applicable | Active not recruiting | Kidney Disease, Chronc Kidney Disease Stage 5, Chronic Kidney Disease | 128 | Turkey (Türkiye) | clinicaltrials.gov |
| July 28, 2026 | NCT07730996 | A Dietitian-Driven Unified Nutritional Care Model (ADDUCE) | Gødstrup Hospital | Not applicable | Recruiting | Hospitalized Adult Patients, Inpatient Internal Medicine Patients, Haematologic Disease, Pulmonary Diseases, Infectious... | 216 | Denmark | clinicaltrials.gov |
| July 24, 2026 | NCT07724288 | Designing and Implementing a Safety Net Surveillance Program for High Risk CKD | University of Manitoba | Not applicable | Not yet recruiting | Chronic Kidney Diseases | 972 | Canada | clinicaltrials.gov |
| July 20, 2026 | NCT07713524 | Recontrast and Renal Outcomes in Patients With Pre-Existing Renal Dysfunction | Cairo University | Observational | Completed | Kidney Diseases | 112 | Egypt | clinicaltrials.gov |
| July 6, 2026 | NCT07685886 | MIRACLE-T2D Montelukast Intervention for Renal, Cardiovascular and Eye Health in Type 2 Diabetes | University of Colorado, Denver | Phase 4 | Not yet recruiting | Diabetes, Kidney Disease, Vascular Disease, Retinopathy | 110 | United States | clinicaltrials.gov |
| July 1, 2026 | NCT07678073 | Comparison of the Effects of General Anesthesia and Combined Spinal-Epidural Anesthesia on Ferroptosis, Humanin and MOTS-c Levels in Renal... | University of Gaziantep | Not applicable | Recruiting | Kidney Disease, End-Stage, Kidney Transplant, Kidney, Kidney Disease, Renal Transplant | 68 | Turkey (Türkiye) | clinicaltrials.gov |
| June 25, 2026 | NCT07668219 | Efficacy of the Use of Real-time Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes and Stage 3 and 4... | Hospital Universitario San Ignacio | Not applicable | Not yet recruiting | Type 2 Diabetes, Kidney Disease, CGM, Time in Range | 30 | Colombia | clinicaltrials.gov |
| June 23, 2026 | NCT07662616 | Team-Based Shared Decision-Making Program in Cardiovascular-Kidney-Metabolic Health (Healthy Heart - CKM) | Johns Hopkins University | Early phase 1 | Not yet recruiting | Hypertension (HTN), Diabetes (DM), Hyperlipidaemia, Kidney Disease, Obesity, Cardiovascular-kidney-metabolic (CKM)... | 94 | clinicaltrials.gov | |
| June 12, 2026 | NCT07646015 | Validate Smart Breath Analyzer as Screening Tool for Diabetic, Hepatic, Renal, Lung, and Other Metabolic Disorders | Respyr | Observational | Completed | Diabetes Mellitus, Type 2, Liver Diseases, Kidney Diseases, Lung Diseases, Metabolic Diseases, Healthy Volunteers | 3,000 | India | clinicaltrials.gov |
| June 11, 2026 | NCT07642050 | A Study to Determine if BHV-1400 is Effective and Safe in Adults With IgA Nephropathy | Biohaven Therapeutics Ltd. | Phase 3 | Not yet recruiting | IgA Nephropathy | 420 | clinicaltrials.gov | |
| May 27, 2026 | NCT07609381 | Clinical Information System Impact on Hospitalized Patients With Chronic Disease | University of Calgary | Observational | Recruiting | Diabete Mellitus, Kidney Disease, Heart Failure, Coronary Artery Disease, Chronic Lung Diseases | 124,240 | Canada | clinicaltrials.gov |
| May 20, 2026 | NCT07600450 | A Study of GSK4771261 in Healthy Participants Aged 25 to 55 Years of Age Inclusive | GlaxoSmithKline | Phase 1 | Recruiting | Kidney Disease | 30 | Netherlands | clinicaltrials.gov |
| May 19, 2026 | NCT07597005 | Red Propolis Supplementation as a Strategy in Chronic Kidney Disease | Universidade Federal Fluminense | Not applicable | Recruiting | Kidney Disease, Oxidative Stress, Chronic Kidney Disease, Inflammation | 40 | Brazil | clinicaltrials.gov |
| May 19, 2026 | NCT07595952 | The Adaptive Platform Trial for Kidney Disease | Nicholas Carlson | Not applicable | Not yet recruiting | Kidney Disease, Chronic Kidney Disease (Stages 4 and 5), End-Stage Kidney Disease (ESKD), Dialysis, Kidney... | 5,000 | clinicaltrials.gov | |
| May 15, 2026 | NCT07591077 | SGLT2 Adjunct in T1D | Ain Shams University | Phase 2/3 | Completed | Type 1 Diabetes, Nephropathy, Diabetic | 86 | Egypt | clinicaltrials.gov |
| May 7, 2026 | NCT07572890 | Adia Med of Winter Park LLC Chronic Kidney Disease Research Study | Adia Med of Winter Park LLC | Phase 1 | Recruiting | Chronic Kidney Disease, Kidney Disease, Kidney Disease, Chronic, Chronic Kidney Disease (CKD), CKD | 100 | United States | clinicaltrials.gov |
| May 1, 2026 | NCT07561957 | A Smart Phone Application to Improve Adoption of the 2024 Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease (CKD)... | St. James's Hospital, Ireland | Not applicable | Recruiting | Chronic Kidney Disease, Proteinuria, Blood Pressure Control, Congenital Anomalies of the Kidneys and Urinary Tract... | 80 | Ireland | clinicaltrials.gov |
| April 22, 2026 | NCT07543549 | Pediatric Renal Emergencies: Presentations and Outcomes at Sohag University Hospitals | Sohag University | Observational | Not yet recruiting | Kidney Diseases | 50 | clinicaltrials.gov | |
| April 21, 2026 | NCT07542964 | Transgender Analysis of Nephrological Studies Focused on Renal Metrics | Amsterdam UMC, location VUmc | Observational | Not yet recruiting | Kidney Disease, Kidney Injury, Transgender Individuals | 60 | Netherlands | clinicaltrials.gov |
| April 21, 2026 | NCT07541287 | A Study of JADE101 in Participants With Immunoglobulin A Nephropathy | Jade Biosciences, Inc. | Phase 2 | Recruiting | IgA Nephropathy | 30 | Australia, New Zealand, South Korea, Taiwan, United States | clinicaltrials.gov |
| April 15, 2026 | NCT07531173 | Serotonin Norepinephrine Reuptake Inhibitors and the Risk of Serious Adverse Events | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Observational | Active not recruiting | Chronic Kidney Disease | 8,688 | clinicaltrials.gov | |
| March 30, 2026 | NCT07501195 | Methods for Nutrition, Inflammation, Kidney Function, Aging, Body Composition, and Hydration Among Older Patients | Ove Andersen | Observational | Recruiting | Malnutrition Elderly, Kidney Diseases, Dehydration | 500 | Denmark | clinicaltrials.gov |
| March 27, 2026 | NCT07498335 | Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Atrasentan in Pediatric Patients With Primary IgAN | Novartis Pharmaceuticals | Phase 3 | Recruiting | Berger Disease, Bergers Disease, IgA Nephropathy, Immunoglobulin A Nephropathy, Primary IgAN, Nephritis IgA Type... | 28 | China, Colombia, France, Japan, South Korea, Spain, Taiwan, United States | clinicaltrials.gov |
| March 25, 2026 | NCT07492511 | Renal and Hepatic Abnormal Doppler Patterns in Trauma | Azienda Usl di Bologna | Observational | Recruiting | Trauma (Including Fractures), Trauma Patients, Kidney Disease, Hypovolemia, Hypervolemia, Kidney Failure | 350 | Italy | clinicaltrials.gov |
| March 20, 2026 | NCT07485075 | Digital Support for Reducing Salt Intake Among Patients With Diabetic Kidney Disease: Protocol for a Controlled Clinical Trial | Steno Diabetes Center Copenhagen | Not applicable | Recruiting | Diabetes Type 2, Kidney Disease | 104 | Denmark | clinicaltrials.gov |
| March 19, 2026 | NCT07483827 | A Clinical Trial to Test the Safety, Tolerability, and How the Body Processes CPV-104 in Healthy People and Patients With C3-Glomerulopathy | eleva GmbH | Phase 1 | Recruiting | C3 Glomerulopathy (C3G), Healthy Adult Participants | 39 | Austria, Belgium, Czechia, France, Greece, Latvia, Lithuania, Netherlands... | clinicaltrials.gov |
| March 12, 2026 | NCT07465926 | Early Add-On Combination of GLP-1 Receptor Agonist and SGLT2 Inhibitor in People With Cardiovascular-Kidney-Metabolic Stage 2-3 | Chung Shan Medical University | Observational | Completed | Cardiovascular-kidney-metabolic Syndrome, Cardiovascular Disease Risk Factor, Kidney Disease, Type 2 Diabetes, Obesity... | 451,036 | clinicaltrials.gov | |
| March 2, 2026 | NCT07444203 | Transformative Research in Diabetic Nephropathy 2.0 | University of Pennsylvania | Observational | Recruiting | Diabetic Nephropathies, Kidney Diseases, Renal Insufficiency, Chronic, Diabetes Mellitus, Type 2 | 200 | United States | clinicaltrials.gov |
| February 27, 2026 | NCT07435844 | Effect of Comprehensive Spa Care on Kidney and Urological Conditions: A Clinical Study in Adult Patients | Institute of Spa and Balneology, public research institution | Not applicable | Recruiting | Urologic Diseases, Urinary Tract Infections, Nephrolithiasis, Nephrocalcinosis, Prostatism, Kidney Diseases | 150 | Czechia | clinicaltrials.gov |
| February 25, 2026 | NCT07431931 | Optimizing Referral Pathways for Patients With Hematuria and Moderate-Severe Proteinuria | Geisinger Clinic | Not applicable | Not yet recruiting | Referral and Consultation, Glomerulonephritis, Hematuria, Proteinuria, Kidney Disease | 1,200 | United States | clinicaltrials.gov |
| February 23, 2026 | NCT07426380 | A Study of Eloralintide (LY3841136) in Participants With Renal Impairment and in Participants With Normal Renal Function | Eli Lilly and Company | Phase 1 | Active not recruiting | Kidney Disease, Renal Insufficiency Chronic, Kidney Failure, Chronic, Renal Impairment, Renal Insufficiency, End Stage... | 28 | United States | clinicaltrials.gov |
| February 19, 2026 | NCT07419945 | Older Kidney Patient Optimisation Pretransplant | Guy's and St Thomas' NHS Foundation Trust | Not applicable | Not yet recruiting | Kidney Disease, Kidney Failure, Frailty, Cognitive Impairment, Multimorbidity, End Stage Kidney Disease (ESRD), Kidney... | 50 | clinicaltrials.gov | |
| February 17, 2026 | NCT07411937 | Kynurenine Concentrations During Pregnancy in Women With or Without Chronic Kidney Disease - A Prospective Multicenter Study | CHU de Reims | Not applicable | Not yet recruiting | Chronic Kidney Diseases, Pregnancy, Preeclampsia | 204 | France | clinicaltrials.gov |
| February 11, 2026 | NCT07403669 | Cardiovascular Kidney and Metabolic Health Assessment and Patient Empowerment | Aventyn, Inc. | Not applicable | Recruiting | Acute MI, Heart Failure, Diabetes Mellitus, Kidney Disease | 300 | Sweden, United States | clinicaltrials.gov |
| February 9, 2026 | NCT07396155 | Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cell Therapy in Diabetic Nephropathy Patients: A Clinical Trial | PT. Prodia Stem Cell Indonesia | Phase 1/2 | Recruiting | Diabetic Nephropathy Type 2 | 10 | Indonesia | clinicaltrials.gov |
| February 6, 2026 | NCT07393594 | ID-ENTITY Trial- Evaluating Serial T-ID Monitoring | Transplant Genomics, Inc. | Observational | Enrolling by invitation | Kidney Diseases, Kidney Injury, BK Virus Infection, CMV, TTV Virus | 1,000 | United States | clinicaltrials.gov |
| February 6, 2026 | NCT07392151 | Reversal to Normoglycemia by Treating Prediabetes | Michael Mæng | Phase 3 | Not yet recruiting | Prediabetes, Chronic Coronary Syndrome | 158 | Denmark | clinicaltrials.gov |
| January 30, 2026 | NCT07378514 | Cobas® Lumira Collection of Venous and Capillary Blood Samples for the Research, Optimization and Calibration of New Diagnostic Devices | LumiraDx UK Limited | Observational | Not yet recruiting | Blood Clots, Infection and Inflammatory Reaction, Heart Disease, Kidney Disease, Vitamin K Antagonist, Diabetes, High... | 30,000 | clinicaltrials.gov | |
| January 16, 2026 | NCT07347769 | Study of the Serotype and Genotype of BK Virus in Kidney Transplant Recipients and Their Donors to Identify Individuals at Risk of... | University Hospital, Grenoble | Observational | Recruiting | Nephropathy, Opportunistic Viral Infection, Polyoma Virus Nephropathy, BK Nephropathy, BK Viremia; BKV DNAemia, BK... | 100 | France | clinicaltrials.gov |
| January 16, 2026 | NCT07346417 | Erector Spinae Plane Block Versus Quadratus Lumborum Block | Assiut University | Not applicable | Not yet recruiting | Kidney Diseases | 100 | clinicaltrials.gov | |
| January 12, 2026 | NCT07332819 | Resveratol in Diabetic Nephropathy | Ain Shams University | Phase 2/3 | Completed | Type 1 Diabetic Nephropathy | 60 | Egypt | clinicaltrials.gov |
| December 31, 2025 | NCT07312929 | Machine Learning and Artificial Intelligence Algorithms to Optimize the Performance and Delivery of Acute Dialysis | University of Alberta | Observational | Not yet recruiting | Renal Dialysis, Renal Replacement Therapy, Renal Diseases, Quality Health Care | 7,500 | Canada | clinicaltrials.gov |
| December 22, 2025 | NCT07295808 | Identification and Characterisation of IgA With Nephritogenic Potential in IgA Deposition Nephropathies (Rep-IgAN) | University Hospital, Limoges | Not applicable | Recruiting | Kidney Disease | 150 | France | clinicaltrials.gov |
| December 18, 2025 | NCT07291258 | Long-term Follow-up of the Offspring Born to Mothers With a Solid Organ Transplant, Transplantlines Next Generation | University Medical Center Groningen | Observational | Recruiting | Solid Organ Transplantation, Pregnancy, Long-term Follow-up, Kidney Transplant, Liver Transplant, Pancreas Transplant... | 200 | Netherlands | clinicaltrials.gov |
| December 1, 2025 | NCT07256470 | Salivary Replication of BK Virus in Post-kidney Transplant | Centre Hospitalier Universitaire, Amiens | Not applicable | Not yet recruiting | BK Virus, Salivary Replication, Kidney Transplantation, Nephropathy, DNAemia | 100 | France | clinicaltrials.gov |
| November 21, 2025 | NCT07241494 | Evaluation of Clinical Pharmacy Services and Drug Use in Renal Impairment. | Istanbul University - Cerrahpasa | Not applicable | Completed | Renal Impairments, Chronic Kidney Disease, Acute Kidney Disease, Medication Errors | 160 | Turkey (Türkiye) | clinicaltrials.gov |
| November 21, 2025 | NCT07241390 | A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney... | Eli Lilly and Company | Phase 3 | Recruiting | Atherosclerosis Cardiovascular Disease, Chronic Kidney Disease | 7,140 | Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, China... | clinicaltrials.gov |
| October 21, 2025 | NCT07219121 | Sparsentan in Posttransplant Immunoglobulin A Nephropathy or Focal Segmental Glomerulosclerosis | Travere Therapeutics, Inc. | Phase 4 | Active not recruiting | Proteinuria, Immunoglobulin A (IgA) Nephropathy, Focal Segmental Glomerulosclerosis, Kidney Transplant | 20 | United States | clinicaltrials.gov |
| October 16, 2025 | NCT07217535 | Rutgers University Study of the Genetics of Kidney Disease | Rutgers, The State University of New Jersey | Observational | Recruiting | Kidney Disease, Kidney Disease, Chronic, Kidney Disease, End-Stage, Kidney Diseases, Kidney Diseases, Chronic, Kidney... | 50,000 | United States | clinicaltrials.gov |
| October 2, 2025 | NCT07202858 | Validation of STARZ Score for Early Neonatal AKI | Assiut University | Observational | Not yet recruiting | Acute Kidney Injury, Kidney Diseases, Newborn | 140 | clinicaltrials.gov | |
| September 26, 2025 | NCT07194733 | Supporting VETerans With Kidney Disease Through Food As Medicine | VA Eastern Colorado Health Care System | Not applicable | Recruiting | Kidney Diseases, Food/Nutrition Insecurity, Diabetes, Hypertension | 20 | United States | clinicaltrials.gov |
| September 23, 2025 | NCT07187713 | ACE Reno, Pico Cell Matrix and Its Effect on eGFR in Chronic Kidney Diseases | Ace Cells Lab Limited | Phase 4 | Recruiting | Hypertensive Nephropathy, Auto Immune Disorders, Chronic Kidney Disease, Chronc Kidney Disease Stage 5, Chronic Kidney... | 300 | Egypt | clinicaltrials.gov |
| September 23, 2025 | NCT07187596 | Mortality Outcome of Controlled Hypertension | DejthidaNathaphong | Observational | Active not recruiting | Hypertension, Morality, Death, Pre-Eclampsia, Cardiovascular Diseases, Stroke, Renal Disease, Artery Stenosis, Arterial... | 2,547 | Thailand | clinicaltrials.gov |
| September 23, 2025 | NCT07187479 | Outcomes of Physiologic Insulin Resensitization (PIR) in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellitus | Well Cell Global | Not applicable | Recruiting | Chronic Kidney Disease (Stages 4 and 5), Kidney Disease, Type 2 Diabetes | 120 | United States | clinicaltrials.gov |
| September 19, 2025 | NCT07182227 | PS-002 for the Treatment of IgA Nephropathy in Adults | Purespring Therapeutics Limited | Phase 1/2 | Recruiting | Immunoglobulin A (IgA) Nephropathy | 32 | United Kingdom, United States | clinicaltrials.gov |
| September 18, 2025 | NCT07181135 | FINE-START: Efficacy and Safety of Finerenone in Patients With Chronic Kidney Disease Not Using Renin-angiotensin-system Inhibitors | University Medical Center Groningen | Phase 3 | Enrolling by invitation | Chronic Kidney Disease | 180 | Spain | clinicaltrials.gov |
| September 11, 2025 | NCT07168356 | A Study to Evaluate Blood Levels of Bepirovirsen in Adult Participants With Severe or Moderate Kidney Disease | GlaxoSmithKline | Phase 1 | Active not recruiting | Hepatitis B | 32 | United States | clinicaltrials.gov |
| September 3, 2025 | NCT07151339 | Pilot Project Renal and Cardiovascular Tertiary Prevention in Preeclampsia | University Hospital Schleswig-Holstein | Observational | Recruiting | Preeclampsia, HELLP Syndrome, Eclampsia, Kidney Disease | 100 | Germany | clinicaltrials.gov |
| September 2, 2025 | NCT07150338 | Outcome of Use of a Novel Modulator of Oxidative Phosphorylation on Kidney Function in Patients With Progressive Chronic Kidney Disease | Neukidney Inc. | Observational | Completed | Chronic Kidney Disease (Stage 3-4), Chronic Kidney Disease (Stages 4 and 5), Proteinuria | 45 | United States | clinicaltrials.gov |
| September 2, 2025 | NCT07149337 | Assessing How the Body Responds to Increased Phosphate Intake, and How This Response Depends on Age and Sex. | University of Zurich | Not applicable | Not yet recruiting | Aging, Kidney Disease, Mineral Metabolism | 40 | clinicaltrials.gov | |
| August 24, 2025 | NCT07138521 | Optimizing Linezolid Dosing in Patients With Advanced Renal Impairment: a Therapeutic Drug Monitoring-based Evaluation | Alexandria University | Phase 4 | Not yet recruiting | Kidney Disease | 50 | clinicaltrials.gov | |
| August 19, 2025 | NCT07128966 | Direct to Patient Minimal Risk Biospecimen and Data Collection Research | Joined Bio | Observational | Recruiting | Healthy, Lupus, Celiac, Kidney Disease, Chronic, Dermatologic | 100,000 | United States | clinicaltrials.gov |
| August 13, 2025 | NCT07119424 | Multidisciplinary Dissection of Renal and Metabolic Effects of Glyfozines on Elderly Patients: From Molecular Aspects to Clinical... | Chiara Lanzani | Observational | Recruiting | Elderly Patients (>65 Years), Diabetes (DM), Heart Disease, Renal Diseases, Internal Disease | 300 | Italy | clinicaltrials.gov |
| July 11, 2025 | NCT07059962 | Sensor-based Congestion ALert for Events in Peritoneal Dialysis (SCALE-PD) | Bodyport Inc. | Observational | Recruiting | Kidney Disease, Peritoneal Dialysis (PD), End Stage Kidney Disease (ESRD) | 125 | Canada, United States | clinicaltrials.gov |
| July 8, 2025 | NCT07054684 | Study of BHV-1400 in IgA Nephropathy | Biohaven Therapeutics Ltd. | Phase 1 | Recruiting | IgA Nephropathy | 20 | United Kingdom, United States | clinicaltrials.gov |
| June 29, 2025 | NCT07042698 | Evaluation of the Performance of Glomerular Filtration Rate Measurement Using CT Urography in Patients With a GFR Below 60 mL/Min/1.73 m² | Assistance Publique - Hôpitaux de Paris | Not applicable | Not yet recruiting | Kidney Diseases, Tomography, X-Ray Computed | 70 | France | clinicaltrials.gov |
| June 24, 2025 | NCT07033117 | RaDIANT Health Systems Intervention | Indiana University | Not applicable | Recruiting | End Stage Renal Disease (ESRD), Kidney Disease | 14,000 | United States | clinicaltrials.gov |
| June 15, 2025 | NCT07022574 | Autoimmune Protocol Diet Intervention on Proteinuria in IgA Nephropathy Patients | University of California, Los Angeles | Not applicable | Withdrawn | IgA Nephropathy (IgAN) | 0 | United States | clinicaltrials.gov |
| June 13, 2025 | NCT07021014 | NightWare and Cardiovascular Health in Women With PTSD | University of Colorado, Denver | Not applicable | Recruiting | Post Traumatic Stress Disorder, Cardiovascular Diseases, Autonomic Dysfunction, Vascular Stiffness, Nightmare... | 36 | United States | clinicaltrials.gov |
| June 12, 2025 | NCT07017556 | Views on Information Resources for Kidney Transplantation Patients | University of Auckland, New Zealand | Not applicable | Not yet recruiting | End-Stage Renal Disease | 60 | New Zealand | clinicaltrials.gov |
| June 8, 2025 | NCT07010250 | Epithelial Dysmetabolism and Renal Fibrosis in ANCA Vasculitis | Assistance Publique - Hôpitaux de Paris | Observational | Recruiting | ANCA Associated Vasculitis, Extramembranous Glomerulopathy, Nephrotic Syndrome, Minimal Change, Interstitial Nephritis... | 146 | France | clinicaltrials.gov |
| June 5, 2025 | NCT07006831 | A Multicenter, Prospective Blood Collection Study in a Kidney Transplant Population | Devyser Inc. | Observational | Recruiting | Kidney Disease, Kidney Transplant, Transplant Recipient, Renal Function, Cell-free DNA, NGS | 400 | United States | clinicaltrials.gov |
| May 21, 2025 | NCT06983028 | Atacicept in Multiple Glomerular Diseases | Vera Therapeutics, Inc. | Phase 2 | Recruiting | pMN, IgAN, Nephrotic Syndrome, MCD, FSGS | 250 | United States | clinicaltrials.gov |
| May 20, 2025 | NCT06980922 | The Efficacy and Safety of Guilu Erxian Jiao in the Treatment of Intradialytic Hypotension | Chang Gung Memorial Hospital | Phase 2 | Not yet recruiting | Intradialytic Hypotension, End-Stage Renal Disease, Hemodialysis | 34 | Taiwan | clinicaltrials.gov |
| May 13, 2025 | NCT06968130 | Effects of Virtual Reality and Breathing Exercises on Hemodialysis Patients' Symptoms and Quality of Life | Trakya University | Not applicable | Active not recruiting | Kidney Diseases | 159 | Turkey (Türkiye) | clinicaltrials.gov |
| May 11, 2025 | NCT06966258 | Inspire HER: Inspiring the Heart and Emotions for Radical Health | University of Alabama at Birmingham | Not applicable | Recruiting | Cardiovascular-kidney-metabolic Syndrome, Cardiovascular Diseases, Hypertension, Diabetes, Hyperlipidemia, Kidney... | 90 | United States | clinicaltrials.gov |
| May 9, 2025 | NCT06963970 | Using Community Health Workers to Support Rural Care Partners of Seriously Ill Older Veterans | VA Office of Research and Development | Not applicable | Not yet recruiting | Dementia, Cancer, Renal Disease, Obstructive Pulmonary Disease | 480 | United States | clinicaltrials.gov |
| May 9, 2025 | NCT06963827 | A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy | Takeda | Phase 3 | Recruiting | Kidney Disease | 347 | Argentina, Australia, Austria, Canada, China, Czechia, France, Germany, Hong... | clinicaltrials.gov |
| May 4, 2025 | NCT06956872 | Clinical Effectiveness of MyNutriKidney® | Universiti Putra Malaysia | Not applicable | Not yet recruiting | Chronic Kidney Disease Stage 3, Chronic Kidney Disease, Chronic Kidney Disease Stage 5, Chronic Kidney Disease Stage 4 | 200 | Malaysia | clinicaltrials.gov |
| April 27, 2025 | NCT06947772 | Skill Building Education of Arteriovenous-Fistula Self-Care Behaviors and Quality of Life of Patients on Hemodialysis | Shifa Tameer-e-Millat University | Not applicable | Not yet recruiting | Chronic Kidney Disease, Hemodialysis, Hemodialysis Access Failure | 274 | Pakistan | clinicaltrials.gov |
| April 24, 2025 | NCT06942910 | A Study to Investigate the Effects of Zibotentan/Dapagliflozin Combination Compared to Dapagliflozin Alone in Adult Participants With... | AstraZeneca | Phase 2 | Active not recruiting | Chronic Kidney Disease With High Proteinuria | 224 | Russia | clinicaltrials.gov |
| April 20, 2025 | NCT06936293 | Effects of Mindfulness Meditation on Hemodialysis Patients | University of Jordan | Not applicable | Completed | End-Stage Renal Disease, Hemodialysis Complication | 56 | Kuwait | clinicaltrials.gov |
| April 4, 2025 | NCT06912490 | Proteomic Analysis of Amniotic Fluid to Predict Postnatal Renal Function in Fetuses With Renal and Urinary Tract Malformations | University Hospital, Toulouse | Not applicable | Recruiting | Kidney Diseases | 78 | France | clinicaltrials.gov |
| April 4, 2025 | NCT06912425 | Effects of an Exercise and Diet Program on Biochemistry and Body Composition in Patients With CKD in G1 and G2 Stages | University of Guadalajara | Not applicable | Completed | Kidney Diseases, Diet, Healthy, Dietary Habits, Exercise, Kidney Disease, Educational, Body Composition, Renal Failure... | 15 | Mexico | clinicaltrials.gov |
Sponsors posting most
| Sponsor | New trials | Latest |
|---|---|---|
| IRCCS Azienda Ospedaliero-Universitaria di Bologna | 5 | February 4, 2025 |
| Assiut University | 4 | August 25, 2026 |
| Assistance Publique - Hôpitaux de Paris | 4 | June 29, 2025 |
| University of Colorado, Denver | 3 | July 6, 2026 |
| GlaxoSmithKline | 3 | May 20, 2026 |
| Novartis Pharmaceuticals | 3 | March 27, 2026 |
| Jade Biosciences, Inc. | 2 | October 29, 2026 |
| Cairo University | 2 | August 11, 2026 |
| Biohaven Therapeutics Ltd. | 2 | June 11, 2026 |
| Ain Shams University | 2 | May 15, 2026 |
| Eli Lilly and Company | 2 | February 23, 2026 |
| University Medical Center Groningen | 2 | December 18, 2025 |
| Wake Forest University Health Sciences | 2 | December 24, 2024 |
| Rachel Miller | 1 | November 2, 2026 |
| University of Lahore | 1 | October 23, 2026 |
| Shanghai Pudong Hospital | 1 | October 15, 2026 |
| The University of Queensland | 1 | October 2, 2026 |
| Incyte Corporation | 1 | October 2, 2026 |
| Virginia Commonwealth University | 1 | September 30, 2026 |
| The Methodist Hospital Research Institute | 1 | August 31, 2026 |
By phase
| Phase | New trials | Latest |
|---|---|---|
| Observational | 50 | November 2, 2026 |
| Not applicable | 47 | October 23, 2026 |
| Phase 3 | 10 | October 29, 2026 |
| Phase 1 | 8 | October 2, 2026 |
| Phase 4 | 7 | September 30, 2026 |
| Phase 2 | 6 | April 21, 2026 |
| Phase 2/3 | 2 | May 15, 2026 |
| Phase 1/2 | 2 | February 9, 2026 |
| Early phase 1 | 1 | June 23, 2026 |
By country
| Country | New trials | Latest |
|---|---|---|
| United States | 44 | November 2, 2026 |
| France | 14 | March 27, 2026 |
| Italy | 10 | March 25, 2026 |
| Canada | 9 | August 20, 2026 |
| Spain | 9 | August 14, 2026 |
| Egypt | 7 | August 11, 2026 |
| Netherlands | 7 | May 20, 2026 |
| Turkey (Türkiye) | 6 | July 31, 2026 |
| Australia | 6 | April 21, 2026 |
| Taiwan | 6 | April 21, 2026 |
| Germany | 6 | November 21, 2025 |
| United Kingdom | 6 | November 21, 2025 |
| China | 5 | October 15, 2026 |
| South Korea | 5 | April 21, 2026 |
| Thailand | 4 | October 2, 2026 |
| Denmark | 4 | July 28, 2026 |
| Czechia | 4 | March 19, 2026 |
| Sweden | 4 | March 19, 2026 |
| Malaysia | 4 | November 21, 2025 |
| Colombia | 3 | June 25, 2026 |
| New Zealand | 3 | April 21, 2026 |
| Japan | 3 | March 27, 2026 |
| Austria | 3 | March 19, 2026 |
| Belgium | 3 | March 19, 2026 |
| Greece | 3 | March 19, 2026 |
Where the register publishes
U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.